Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Deficiency of the mitochondrial enzyme 2-methyl-3-hydroxybutyryl-CoA dehydrogenase involved in isoleucine metabolism causes an organic aciduria with atypical neurodegenerative course. The disease-causing gene is HSD17B10 and encodes 17beta-hydroxysteroid dehydrogenase type 10 (HSD10), a protein also implicated in the pathogenesis of Alzheimer's disease. Here we show that clinical symptoms in patients are not correlated with residual enzymatic activity of mutated HSD10. Loss-of-function and rescue experiments in Xenopus embryos and cells derived from conditional Hsd17b10(-/-) mice demonstrate that a property of HSD10 independent of its enzymatic activity is essential for structural and functional integrity of mitochondria. Impairment of this function in neural cells causes apoptotic cell death whilst the enzymatic activity of HSD10 is not required for cell survival. This finding indicates that the symptoms in patients with mutations in the HSD17B10 gene are unrelated to accumulation of toxic metabolites in the isoleucine pathway and, rather, related to defects in general mitochondrial function. Therefore alternative therapeutic approaches to an isoleucine-restricted diet are required.

Original publication

DOI

10.1002/emmm.200900055

Type

Journal article

Journal

EMBO Mol Med

Publication Date

02/2010

Volume

2

Pages

51 - 62

Keywords

3-Hydroxyacyl CoA Dehydrogenases, Animals, Apoptosis, Cell Survival, Cells, Cultured, Fibroblasts, Gene Deletion, Genetic Complementation Test, Humans, Hydroxysteroid Dehydrogenases, Infant, Mice, Mice, Knockout, Mitochondria, Models, Molecular, Neurons, Protein Structure, Tertiary, Xenopus